Nitroglycerin API Market Report 2025 (Global Edition)

Global Nitroglycerin API Market Report 2025 Market Size Split by Type (10% NG, 5% NG, 2 15% NG.), by End Use (Intravenous, Sublingual Spray, Nitroglycerin Patch)

Nitroglycerin API Market Report Description

We have various report editions of Nitroglycerin API Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Nitroglycerin API Market Insights Video

Competitive Landscape of the Nitroglycerin API Market

The Nitroglycerin API market exhibits a competitive landscape with key players vying for market share. Emerging players from Asia-Pacific pose a growing threat with their competitive pricing and expanding global presence. Overall, intense competition persists, driven by innovation, regulatory compliance, and market expansion strategies.

Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for the first generic version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity. Cosette will imminently commence commercial shipments, triggering the 180 days exclusivity. (Source: https://finance.yahoo.com/news/cosette-pharmaceuticals-announces-approval-launch-133000723.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAB9nnXT4DzttSfp2jKR1mHKx7UUoJa0Qzb73zY4-bmpcrAXag4cPlVaSfp43cXVR8rKzLZT_GP6bYAWOyFiFpzdqRRrttoL47NN4rkg6VWD-wDqHyil8EU3B3z16VzRFMpNuxB8o6F1qgc9PZs3RUa3g21orrICROvZ5QNSSJlrX)

Top Companies Market Share in Nitroglycerin API Industry: (In no particular order of Rank)

• Novasep (France)
• Copperhead Chemical (US.)
• Dipharma (Italy)
• Cambrex (US.)
• Bharat Pharma (India)
• SD Sinepharm (Beijing)
• Dorsa Pharmaceutical (India)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Nitroglycerin API Market

Which Region Dominates the Nitroglycerin API Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. North America's dominance in the Nitroglycerin API market can be attributed to several factors. Firstly, the region boasts a robust healthcare infrastructure and a high prevalence of cardiovascular diseases, for which nitroglycerin is a primary treatment option. Moreover, favorable government policies, advanced research and development facilities, and strong collaborations between pharmaceutical companies contribute to the market's growth in this region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific region is experiencing rapid expansion in the Nitroglycerin API market due to increasing healthcare expenditure, growing awareness about cardiovascular diseases, and rising demand for effective treatments. Additionally, the presence of a large patient population, particularly in countries like India and China, further fuels market growth.

 

The current report Scope analyzes Nitroglycerin API Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Nitroglycerin API Market Analysis

According to Cognitive Market Research, the global Nitroglycerin API market size was estimated at USD 22.9 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 9.16 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• The North American nitroglycerin API market showcases robust growth driven by its extensive applications in pharmaceuticals, particularly in cardiovascular treatments.
• The dominating segment lies within the pharmaceutical sector, owing to nitroglycerin's efficacy in treating angina and heart-related conditions. This segment benefits from increasing healthcare expenditure and a rising prevalence of cardiovascular diseases in the region.
• Additionally, technological advancements in drug delivery systems further enhance nitroglycerin's market penetration.
• In conclusion, the North American nitroglycerin API market exhibits promising growth prospects fueled by expanding pharmaceutical applications and supportive healthcare infrastructure. The dominance of the pharmaceutical segment underscores nitroglycerin's vital role in addressing cardiovascular ailments, solidifying its position as a cornerstone therapeutic agent in the region's healthcare landscape.
• According to Cognitive Market Research, the US had a major share in the Nitroglycerin API market with a market size of USD 7.23 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period—demand for nitroglycerin API in the US driven by cardiovascular drug production, healthcare advancements, and research innovation.
• The Canada Nitroglycerin API market had a market share of USD 1.10 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Increased demand for cardiovascular medications, advancements in drug formulations, and expanding healthcare infrastructure drive the nitroglycerin API market in Canada.
• The Mexico Nitroglycerin API market is projected to witness growth at a CAGR of 4.7%during the forecast period with a market size of USD 0.83 million in 2024.

Europe Nitroglycerin API Market Analysis

According to Cognitive Market Research, the global Nitroglycerin API market size was estimated at USD 22.9 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 6.87 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

• The European market for Nitroglycerin API (Active Pharmaceutical Ingredient) showcases steady growth, primarily driven by its widespread application in cardiovascular treatments.
• The dominating segment within this market is pharmaceuticals, with nitroglycerin's established role in managing conditions like angina and heart failure. Its vasodilatory properties make it a cornerstone therapy in cardiology, ensuring its sustained demand. Despite stringent regulations and safety concerns associated with its handling, advancements in formulation techniques and drug delivery systems continue to enhance its efficacy and safety profile.
• In conclusion, the Nitroglycerin API market in Europe is poised for continued expansion, fueled by the growing prevalence of cardiovascular diseases and ongoing innovations in pharmaceutical technology. Adherence to regulatory standards and strategic collaborations will be pivotal in capitalizing on emerging opportunities within this dynamic sector.
• The United Kingdom Nitroglycerin API market had a market share of USD 1.15 million in 2024 and is projected to grow at a CAGR of 5.3%during the forecast period. Demand for cardiovascular drugs, technological advancements, and the increasing prevalence of heart diseases boost the nitroglycerin API market.
• The France Nitroglycerin API market is projected to witness growth at a CAGR of 3.7%during the forecast period with a market size of USD 0.63 million in 2024.
• According to Cognitive Market Research, the German nitroglycerin API market size was valued at USD 1.36 million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period—increased demand for cardiovascular medications, advancements in drug delivery technology, and rising healthcare expenditure.
• The Italy Nitroglycerin API market is projected to grow at a CAGR of 3.9% during the forecast period, reaching a market size of USD 0.59 million in 2024.
• The Russian nitroglycerin API market is projected to grow at a CAGR of 3.5% during the forecast period, reaching a market size of USD 1.06 million in 2024.
• The Spanish nitroglycerin API market is projected to grow at a CAGR of 3.6% during the forecast period, reaching a market size of USD 0.56 million in 2024.
• The Luxembourg Nitroglycerin API market is projected to grow at a CAGR of 4.6% during the forecast period, reaching a market size of USD 0.21 million in 2024.
• The Portugal Nitroglycerin API market is projected to witness growth at a CAGR of 4.3%during the forecast period with a market size of USD 0.14 million in 2024.
• The Greece Nitroglycerin API market is projected to witness growth at a CAGR of 4.8%during the forecast period with a market size of USD 0.08 million in 2024.
• The Rest of Europe's Nitroglycerin API market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 1.06 million in 2024.

Asia Pacific Nitroglycerin API Market Analysis

According to Cognitive Market Research, the global Nitroglycerin API market size was estimated at USD 22.9 Million, out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD 5.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0%from 2024 to 2031.

• The Nitroglycerin API market in the Asia Pacific region is experiencing robust growth, driven primarily by the expanding demand for cardiovascular drugs and explosives in various industries.
• The dominating segment within this market is pharmaceuticals, owing to the widespread use of nitroglycerin in treating heart conditions like angina.
• Additionally, the region's thriving construction and mining sectors contribute to the demand for nitroglycerin in explosive applications.
• In conclusion, the Asia Pacific Nitroglycerin API market presents lucrative opportunities for both pharmaceutical and industrial sectors due to its versatile applications. However, stringent regulations regarding its handling and transportation pose challenges for market players. Nevertheless, strategic collaborations and technological advancements are anticipated to propel market growth further in the foreseeable future.
• According to Cognitive Market Research, the China Nitroglycerin API market size was valued at USD 2.37 million in 2024 and is projected to grow at a CAGR of 7.5%during the forecast period. Rising demand for cardiovascular drugs, expanding healthcare infrastructure, and increasing research activities drive the nitroglycerin API market in China.
• The Japan Nitroglycerin API market is projected to grow at a CAGR of 6.5% during the forecast period, reaching a market size of USD 0.73 million in 2024.
• The India Nitroglycerin API market had a market share of USD 0.63 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. Growing demand for cardiovascular drugs, technological advancements, increasing healthcare expenditure, and rising awareness propel the market.
• The South Korean nitroglycerin API market is projected to grow at a CAGR of 7.1% during the forecast period, reaching a market size of USD 0.53 million in 2024.
• The Australian nitroglycerin API market is projected to grow at a CAGR of 7.7% during the forecast period, reaching a market size of USD 0.27 million in 2024.
• The South East Asia Nitroglycerin API market is projected to grow at a CAGR of 9.0% during the forecast period, reaching a market size of USD 0.36 million in 2024.
• The Rest of the Asia Pacific Nitroglycerin API market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 0.37 million in 2024.

South America Nitroglycerin API Market Analysis

According to Cognitive Market Research, the global Nitroglycerin API market size was estimated at USD 22.9 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 1.15 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4%from 2024 to 2031.

• The Nitroglycerin API market in Latin America showcases steady growth driven by increasing applications in the pharmaceuticals and explosives industries.
• The pharmaceutical segment dominates due to nitroglycerin's efficacy in treating heart conditions like angina.
• Additionally, its use in explosives for mining and construction further bolsters market demand. However, stringent regulations regarding storage, transportation, and handling pose challenges. Despite this, technological advancements and investments in infrastructure are expected to drive market expansion.
• In conclusion, Latin America's Nitroglycerin API market presents lucrative opportunities, primarily led by pharmaceutical applications, yet with the potential for further growth in explosives sectors. Adherence to regulations and continued innovation will be key for stakeholders to harness the market's full potential.
• According to Cognitive Market Research, the Brazil Nitroglycerin API market size was valued at USD 0.49 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Brazil's Nitroglycerin API market is driven by demand in pharmaceuticals, explosives, and construction; regulations influence growth.
• The Argentina Nitroglycerin API market had a market share of USD 0.19 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. Healthcare reforms, infrastructure development, and pharmaceutical industry growth likely drive demand for nitroglycerin API in Argentina.
• The Colombia Nitroglycerin API market is projected to witness growth at a CAGR of 5.2%during the forecast period with a market size of USD 0.10 million in 2024.
• The Peru Nitroglycerin API market is projected to grow at a CAGR of 5.6% during the forecast period, reaching a market size of USD 0.09 million in 2024.
• The Chilean nitroglycerin API market is projected to grow at a CAGR of 5.7% during the forecast period, reaching a market size of USD 0.08 million in 2024.
• The Rest of Latin America Nitroglycerin API market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 0.18 million in 2024.

Middle East Nitroglycerin API Market Analysis

According to Cognitive Market Research, the global Nitroglycerin API market size was estimated at USD 22.9 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 0.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031.

• The Nitroglycerin API market in the Middle East and Africa (MEA) region exhibits steady growth, driven by expanding industrial and healthcare sectors.
• In MEA, the dominating segment is pharmaceuticals, owing to the rising prevalence of cardiovascular diseases and the increasing demand for nitroglycerin-based medications.
• Additionally, the industrial segment shows promise due to infrastructure development projects and the growing use of nitroglycerin in explosives. However, regulatory constraints and safety concerns pose challenges to market expansion.
• In conclusion, while the pharmaceutical sector remains the primary revenue generator, diversification into industrial applications presents opportunities for market players in the MEA region. Strategic measures to address regulatory hurdles and ensure safety standards will be pivotal for sustained growth in the Nitroglycerin API market in MEA.
• The GCC Countries' Nitroglycerin API market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 0.20 million in 2024. Increasing demand for cardiovascular drugs, advancements in healthcare, and rising awareness propel the nitroglycerin API market in the GCC.
• The Egypt Nitroglycerin API market is projected to grow at a CAGR of 6.0% during the forecast period, reaching a market size of USD 0.05 million in 2024.
• The South African nitroglycerin API market is projected to grow at a CAGR of 6.7% during the forecast period and reach USD 0.07 million in 2024. Emerging healthcare demands, industrial applications, and research drive market growth in South Africa.
• The Turkey Nitroglycerin API market is projected to grow at a CAGR of 5.2% during the forecast period, reaching a market size of USD 0.04 million in 2024.
• The Nigeria Nitroglycerin API market is projected to grow at a CAGR of 4.8% during the forecast period, reaching a market size of USD 0.05 million in 2024.
• The Rest of MEA Nitroglycerin API market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD 0.05 million in 2024.

Nitroglycerin API Market Analysis

Nitroglycerin API Market Type Segment Analysis

The 10% NG variant represents a substantial portion of the market, indicating its significance in various applications. Its higher concentration implies potentially greater potency or efficacy in certain contexts, driving demand from industries such as pharmaceuticals, where precise dosages are critical for therapeutic effectiveness. Additionally, the 10% formulation can be used in specialized industrial applications where a stronger explosive is required, such as in mining or construction.

In contrast, the 5% NG formulation, while comprising a smaller segment, still holds relevance. Its lower concentration may appeal to sectors prioritizing safety or requiring less intense reactions, such as certain medical applications or controlled explosive uses in military or industrial settings.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nitroglycerin API Industry. Request a Free Sample PDF!

Nitroglycerin API Market End-Use Segment Analysis

Intravenous administration involves direct delivery into the bloodstream, providing rapid onset of action, making it suitable for acute situations such as myocardial infarction or severe angina. Hospitals and emergency care settings predominantly utilize IV formulations due to their quick efficacy.

On the other hand, Sublingual Sprays offer a convenient and non-invasive method of administration. They are absorbed directly through the mucous membranes under the tongue, providing rapid relief for angina episodes. Sublingual formulations are often preferred by patients for their ease of use and portability, allowing for self-administration in emergencies.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Ashwini Moharir

Research Analyst at Cognitive Market Research

LinkedIn

Profile

Enthusiastic and analytical market research professional with 2 years of hands-on experience in tracking market trends, evaluating consumer behavior, and supporting strategic decision-making. Proficient in designing surveys, conducting interviews, and synthesizing insights from both primary and secondary sources. Successfully contributed to research projects across sectors such as retail, personal care, and industrial markets. Brings a keen eye for detail, strong data interpretation skills, and a passion for uncovering what drives markets forward. Comfortable working in fast-paced environments and collaborating across departments to deliver clear, actionable findings.

Author's Conclusion